EPO and diabetes mellitus: This stimulatory effect of erythropoiesis mediated by its EPO mimetic property in a model of diabetes with an inflammatory component, coupled with its inhibitory effect in hepcidin synthesis, allow V to exhibit anti-anemic potential in diabetes by a double mechanism: the increase in EPO effectiveness and the increase in iron intestinal absorption [35].